BMI-Related Cores and Resources

The BMI-CE core serves an integral role in providing access to existing clinical and health databases by working with collaborators across the region. We are working with partner institutions and national experts to expand research capabilities and better serve traditionally underserved areas. 

Nebraska Biobank

The Nebraska Biobank is a Nebraska Research Initiative (NRI) developed joint effort of the University of Nebraska Medical Center (UNMC) and Nebraska Medicine to facilitate research in health care. The Nebraska Biobank is made up of residual blood samples from patients who want to take part.


Patients at the Nebraska Medicine clinics and hospitals are being asked at check-in to participate by donating any blood left from their scheduled laboratory tests to the Nebraska Biobank.  Serum, Plasma, and DNA are recovered from the consented samples and stored for future research studies.  De-identified data from the Electronic Health Record (EHR) such as age range, diagnosis, and medications are linked to the stored samples.  Any faculty member from the University of Nebraska system may request samples from the biobank for their research projects but all requests are subject to feasibility and scientific merit review.


The Nebraska Biobank also offers sample management services to investigators for clinical trials and registries.


Learn more about the Nebraska Biobank or contacting Scott Campbell, PhD.


SPARC is the database that the GP IDeA-CTR is using to house an inventory of resources available in the network. Within this database, investigators can search for specific cores or labs, find other researchers with a certain expertise, or discover equipment that may not be available at their home institution.


To view resources available regionally, visit SPARC.


To learn more about SPARC and open data, view the SPARC Landscape Analysis.


Eagle-i is a resource discovery tool built to facilitate translational science research. Groundbreaking biomedical research requires access to cutting edge scientific resources, but those resources are often invisible beyond the laboratories or universities where they were developed. Using eagle-i’s free software, you can collect and share information about your research resources, giving any scientist, anywhere, access to one of the largest collections of information about Core Facilities, iPS cell lines, and other valuable, unique or rare scientific resources in the world.

  • For researchers: Query multiple institutions, connect with other researchers, share or request resources.
  • For institutions: Collect and share information about research resources in a highly organized and accessible way.
  • For developers: Get the open source software and search semantically rich data resources of all kinds.

Services Offered

  • NGS data analysis
  • Array-based and systems biology data services
  • Web pages and databases
  • Machine Learning and research
  • Grant support and consultation
  • Other research related IT support

Electronic Health Records Data Access Core

The Electronic Health Records Data Access Core facility was established to provide research access to electronic health data from our health care information system [EPIC and Legacy EHR data, i.e.Carecast]. Learn more about the EHR Data Access Core or contacting Purnima Guda, PhD.


What Does the EHR Data Access Core Provide?

This core facility provides access to Electronic Health Care data for clinical and translational research.  This may include:

  • Feasibility studies
  • Cross-sectional studies
  • Health outcomes
  • Retrospective data analysis
  • quality improvement projects
  • transfer of datasets to a registry
  • case finding for subject recruitment
  • public health research

Clinical Characterization Protocol for Severe Emerging Infections (CCPSEI)

The University of Nebraska Medical Center and Nebraska Medicine established its variation of the Clinical Characterization Protocol for Severe Emerging Infections (CCPSEI) during the COVID-19 pandemic. CCPSEI is a prospective, observational cohort study that enrolls suspected and confirmed cases of high consequence pathogens, such as pandemic-threat disease, those listed on the U.S. Select Agent list, and other emerging and re-emerging threats that are particularly problematic for patients and communities.The protocol was adapted from the harmonized clinical trial efforts of the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC).

Other Data Management Tools and Services

Contact CCORDA for any issues questions related to research design, data acquisition and management, research ethics, or analysis questions by visiting their homepage or contact Center Director Fang Yu, PhD.